Shah VP - Search Results

1

In vitro release test (IVRT): Principles and applications.

Shah VP, Simona Miron D, Ștefan Rădulescu F, Cardot JM, Maibach HI. Shah VP, et al. Int J Pharm. 2022 Oct 15;626:122159. doi: 10.1016/j.ijpharm.2022.122159. Epub 2022 Sep 5. Int J Pharm. 2022. PMID: 36067919 Review.

2

Workshop report on in vivo percutaneous penetration/absorption. Washington D.C., May 1-3, 1989.

Shah VP, Flynn GL, Guy RH, Maibach HI, Schaefer H, Skelly JP, Wester RC, Yacobi A. Shah VP, et al. Skin Pharmacol. 1991;4(3):220-8. doi: 10.1159/000210952. Skin Pharmacol. 1991. PMID: 1685087 Review. No abstract available.

3

The bioavailability of dermatological and other topically administered drugs.

Guy RH, Guy AH, Maibach HI, Shah VP. Guy RH, et al. Among authors: shah vp. Pharm Res. 1986 Oct;3(5):253-62. doi: 10.1023/A:1016303216873. Pharm Res. 1986. PMID: 24271707

4

A science based approach to topical drug classification system (TCS).

Shah VP, Yacobi A, Rădulescu FŞ, Miron DS, Lane ME. Shah VP, et al. Int J Pharm. 2015 Aug 1;491(1-2):21-5. doi: 10.1016/j.ijpharm.2015.06.011. Epub 2015 Jun 10. Int J Pharm. 2015. PMID: 26070249 Review.

5

Commonality between BCS and TCS.

Shah VP, Rădulescu FŞ, Miron DS, Yacobi A. Shah VP, et al. Int J Pharm. 2016 Jul 25;509(1-2):35-40. doi: 10.1016/j.ijpharm.2016.05.032. Epub 2016 May 18. Int J Pharm. 2016. PMID: 27208656 Review.

6

Rheological and in vitro release measurements of manufactured acyclovir 5% creams: confirming sensitivity of the in vitro release.

Miron DS, Rădulescu FȘ, Voicu VA, Mînea A, Cardot JM, Shah VP. Miron DS, et al. Among authors: shah vp. Pharm Dev Technol. 2021 Sep;26(7):779-787. doi: 10.1080/10837450.2021.1945625. Epub 2021 Jun 30. Pharm Dev Technol. 2021. PMID: 34165370

7

Are European marketed acyclovir 5% cream products similar? Comparison with EU and US reference product.

Miron DS, Rădulescu FȘ, Voicu VA, Mînea A, Cardot JM, Shah VP. Miron DS, et al. Among authors: shah vp. Drug Dev Ind Pharm. 2021 Jun;47(6):990-1000. doi: 10.1080/03639045.2021.1957921. Epub 2021 Jul 27. Drug Dev Ind Pharm. 2021. PMID: 34279163

8

Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerate creams.

Shah VP, Elkins J, Skelly JP. Shah VP, et al. J Pharm Sci. 1992 Jan;81(1):104-6. doi: 10.1002/jps.2600810121. J Pharm Sci. 1992. PMID: 1619561

9

In vivo percutaneous penetration/absorption, Washington, D.C., May 1989.

Shah VP, Flynn GL, Guy RH, Maibach HI, Schaefer H, Skelly JP, Wester RC, Yacobi A. Shah VP, et al. Pharm Res. 1991 Aug;8(8):1071-5. doi: 10.1023/a:1015829729439. Pharm Res. 1991. PMID: 1924164 Free article. No abstract available.

10

Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence.

Shah VP, Flynn GL, Yacobi A, Maibach HI, Bon C, Fleischer NM, Franz TJ, Kaplan SA, Kawamoto J, Lesko LJ, Marty JP, Pershing LK, Schaefer H, Sequeira JA, Shrivastava SP, Wilkin J, Williams RL. Shah VP, et al. Pharm Res. 1998 Feb;15(2):167-71. doi: 10.1023/a:1011941929495. Pharm Res. 1998. PMID: 9523299 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

282 results

Search Page